Cargando…
IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis
The incidence of papillary thyroid cancer (PTC) with concomitant Hashimoto thyroiditis (HT) is increasing. Interleukin (IL)-10 is a cytokine previously reported to be elevated in this condition. Evidence from multiple human malignancies showed IL-10 participated in tumor immunity and exhibited thera...
Autores principales: | Lu, Zhong-Wu, Hu, Jia-Qian, Liu, Wan-Ling, Wen, Duo, Wei, Wen-Jun, Wang, Yu-Long, Wang, Yu, Liao, Tian, Ji, Qing-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469947/ https://www.ncbi.nlm.nih.gov/pubmed/32348468 http://dx.doi.org/10.1210/endocr/bqaa062 |
Ejemplares similares
-
IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro
por: Hu, Jia-Qian, et al.
Publicado: (2020) -
IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis
por: Han, Li-Tao, et al.
Publicado: (2019) -
Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis
por: Subhi, Ohoud, et al.
Publicado: (2020) -
Coexistence of papillary thyroid cancer with Hashimoto thyroiditis
por: Konturek, Aleksander, et al.
Publicado: (2012) -
Thyroid papillary carcinoma associated to Hashimoto's thyroiditis
por: Campos, Luiz Alexandre Albuquerque Freixo, et al.
Publicado: (2015)